LRRK2 and Parkinson disease: This enhancement of PGK1 activity increases dopamine levels, slows or prevents neurodegeneration and improves motor performance in several animal models of PD, such as the MPTP mouse, OHDA rat, and PINK1 and LRRK2 fly models (Cai et al., 2019).